This article presents an overview of Insiders are Piling into These 5 Healthcare Stocks in 2024. For a detailed overview of such stocks read our article, Insiders are Piling into These 10 Healthcare Stocks in 2024.
5. Entrada Therapeutics Inc (NASDAQ:TRDA)
Number of Hedge Fund Investors: 6
Intracellular therapeutics company Entrada Therapeutics Inc (NASDAQ:TRDA) is one of the notable stocks in the healthcare industry with insider buying. On March 19, 2024, Peter S. Kim, a director at Entrada Therapeutics Inc (NASDAQ:TRDA), bought 2732 shares at $12.81 per share. The stock price has jumped 8% since the date of this insider transaction.
4. Rezolute Inc (NASDAQ:RZLT)
Number of Hedge Fund Investors: 10
Biopharma company Rezolute Inc (NASDAQ:RZLT) ranks fourth in our list of the healthcare stocks insiders are buying. Rezolute Inc’s (NASDAQ:RZLT) CFO Daron Evans bought 50,000 shares of Rezolute Inc (NASDAQ:RZLT) on March 8 at $1.93. Since then the stock has gained about 25% in value.
3. Hillevax Inc (NASDAQ:HLVX)
Number of Hedge Fund Investors: 11
Boston, Massachusetts-based Hillevax Inc (NASDAQ:HLVX) makes vaccines against the Norovirus. The stock recently saw insider buying activity when its COO Sean McLoughlin snapped up 1250 shares of Hillevax Inc (NASDAQ:HLVX) at $16.98 per share. The transaction took place on March 28. Since then the stock is down about 10%.
2. Nkarta Inc (NASDAQ:NKTX)
Number of Hedge Fund Investors: 14
California-based allogeneic natural killer (NK) cell therapies company Nkarta Inc (NASDAQ:NKTX) ranks second in our list of the healthcare stocks with recent insider purchases. On March 27, 2024, Simeon George, a director at the company, bought two million shares of Nkarta Inc (NASDAQ:NKTX) at $10 per share. The total value of this transaction was $20 million. Since March 27 through April 3 the stock is down 14%.
As of the end of the fourth quarter of 2023, 14 hedge funds out of the 933 funds tracked by Insider Monkey had stakes in Nkarta Inc (NASDAQ:NKTX).
1. Walgreens Boots Alliance Inc (NASDAQ:WBA)
Number of Hedge Fund Investors: 31
One of the biggest pharmacy chains in the US, Walgreens Boots Alliance Inc (NASDAQ:WBA) shares have lost about 30% so far this year. On April 2, Walgreens Boots Alliance Inc’s (NASDAQ:WBA) EVP and Global CFO Manmohan Mahajan amassed 6,000 shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) at $19.38 per share. Since then the stock has slipped 1.2%.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also look at the 11 Overvalued Stocks Insiders are Dumping Now and the Insiders Are Buying These 11 Penny Stocks.
